Berger Martin, Marx Nikolaus, Marx-Schütt Katharina
Department of Internal Medicine I, University Hospital Aachen Aachen, Germany.
Eur Cardiol. 2025 Apr 15;20:e09. doi: 10.15420/ecr.2024.29. eCollection 2025.
Patients with diabetes are at an increased risk of cardiovascular disease (CVD), including atherosclerotic CVD and heart failure. In addition, diabetes is associated with a higher risk of developing chronic kidney disease, which is considered to be one of the strongest risk factors for CVD and mortality. To address the increased cardiovascular risk of patients with diabetes, dedicated screening strategies for CVD are necessary; conversely, screening for diabetes needs to be performed in all patients with CVD to allow timely identification. Once diabetes is diagnosed, rapid implementation of treatment with therapies to reduce cardiovascular risk on top of standard of care is necessary. This review gives an overview of contemporary therapeutic strategies to reduce cardiovascular risk in patients with type 2 diabetes.
糖尿病患者患心血管疾病(CVD)的风险增加,包括动脉粥样硬化性心血管疾病和心力衰竭。此外,糖尿病与发生慢性肾脏病的较高风险相关,慢性肾脏病被认为是心血管疾病和死亡的最强风险因素之一。为应对糖尿病患者心血管风险增加的问题,有必要采用专门的心血管疾病筛查策略;相反,需要对所有心血管疾病患者进行糖尿病筛查,以便及时识别。一旦诊断出糖尿病,除标准治疗外,迅速采用降低心血管风险的疗法进行治疗是必要的。本综述概述了降低2型糖尿病患者心血管风险的当代治疗策略。